BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tsounis EP, Tourkochristou E, Mouzaki A, Triantos C. Toward a new era of hepatitis B virus therapeutics: The pursuit of a functional cure. World J Gastroenterol 2021; 27(21): 2727-2757 [PMID: 34135551 DOI: 10.3748/wjg.v27.i21.2727]
URL: https://www.wjgnet.com/1948-5182/full/v27/i21/2727.htm
Number Citing Articles
1
Lucie Hozáková, Barbora Vokatá, Tomáš Ruml, Pavel Ulbrich. Targeting the Virus Capsid as a Tool to Fight RNA VirusesViruses 2022; 14(2): 174 doi: 10.3390/v14020174
2
Yi Zhang, Minli Guo, Xinyue Zhang, Nan Zhang, Ping Zhu, Hao Wang. Multiple optimizations of recombinant plasmid for improving expression of Hepatitis B core antigen in Escherichia coliProtein Expression and Purification 2022; 198: 106127 doi: 10.1016/j.pep.2022.106127
3
Xiaojiao Li, Yusi Liu, Hanxin Yao, Meng Wang, Lei Gao, Jinfeng Lou, John Mao, Wenqiang Wu, Yixin Zhou, Yanan Tang, Wenhao Yan, Yanbin Hu, Charles Ding, Shuhui Chen, Junqi Niu, Yanhua Ding. Safety, Tolerability, and Pharmacokinetics of the Novel Hepatitis B Virus Expression Inhibitor GST-HG131 in Healthy Chinese Subjects: a First-in-Human Single- and Multiple-Dose Escalation TrialAntimicrobial Agents and Chemotherapy 2022; 66(5) doi: 10.1128/aac.00094-22
4
Maria Guadalupe Martinez, Emmanuel Combe, Aurore Inchauspe, Philippe Emmanuel Mangeot, Elodie Delberghe, Fleur Chapus, Gregory Neveu, Antoine Alam, Kara Carter, Barbara Testoni, Fabien Zoulim, Jianming Hu, Monica J. Roth. CRISPR-Cas9 Targeting of Hepatitis B Virus Covalently Closed Circular DNA Generates Transcriptionally Active Episomal VariantsmBio 2022; 13(2) doi: 10.1128/mbio.02888-21
5
Cornelis J.M. Melief, Anna-Sophia Wiekmeijer, Esmé T.I. van der Gracht. Cancer Vaccines as Immunotherapy of Cancer2022; : 97 doi: 10.1016/B978-0-12-823901-8.00013-3
6
Percy A. Knolle, Li-Rung Huang, Anna Kosinska, Dirk Wohlleber, Ulrike Protzer. Improving Therapeutic Vaccination against Hepatitis B—Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus InfectionVaccines 2021; 9(11): 1333 doi: 10.3390/vaccines9111333
7
Iman Waheed Khan, Mati Ullah Dad Ullah, Mina Choudhry, Mukarram Jamat Ali, Muhammad Ashar Ali, Sam L. K. Lam, Pir Ahmad Shah, Satinder Pal Kaur, Daryl T. Y. Lau. Novel Therapies of Hepatitis B and DMicroorganisms 2021; 9(12): 2607 doi: 10.3390/microorganisms9122607
8
Tamás Vermes, Mark Kielpinski, Thomas Henkel, Miquel A. Pericàs, Esther Alza, Angelica Corcuera, Helmut Buschmann, Thomas Goldner, Andreas Urban. An automated microfluidic platform for the screening and characterization of novel hepatitis B virus capsid assembly modulatorsAnalytical Methods 2022; 14(2): 135 doi: 10.1039/D1AY01227D
9
Siyu Li, Na Li, Shanru Yang, Haiyan Deng, Yanguo Li, Yixuan Wang, Jiaqiang Yang, Jiaxin Lv, Lan Dong, Guansen Yu, Xin Hou, Geng Wang. The study of immune checkpoint inhibitors in chronic hepatitis B virus infectionInternational Immunopharmacology 2022; 109: 108842 doi: 10.1016/j.intimp.2022.108842